Fibrosis And Pirfenidone

Fibrosis and Pirfenidone

Carlos Remolina

Idiopathic Pulmonary Fibrosis: Pirfenidone

Demystifying Medicine McMaster

Safety and Management of Side Effects of Pirfenidone and Nintedanib | Wendi Mason, MSN

Pulmonary Fibrosis Foundation

Discovering New Drugs for IPF

The France Foundation

Idiopathic Pulmonary Fibrosis - 2018

Pharmacologic Therapy | Charlene Fell, MD, MSc

Pulmonary Fibrosis Foundation

Wound healing in idiopathic pulmonary fibrosis (IPF)

Boehringer Ingelheim Idiopathic Pulmonary Fibrosis

Evaluating New Advances in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases

Idiopathic pulmonary fibrosis: Medical research

Demystifying Medicine McMaster

Overview of Pirfenidone and Nintedanib | Joyce Lee, MD

Pulmonary Fibrosis Foundation

Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults

American Thoracic Society

Pirfenidone and Nintedanib Tips for Treating Patients with Idiopathic Pulmonary

Bolton Pulmonary Fibrosis Support Group

Non-Genetic Causes of Pulmonary Fibrosis Webinar

Pulmonary Fibrosis Foundation

Pirfenidone in Patients with Unclassifiable Interstitial Lung Disease

The France Foundation

Myth #5: I Only Have 3-5 Years To Live

Pulmonary Fibrosis Foundation

Perspective on Side Effect Management Strategies with Pirfenidone and Nintedanib

The France Foundation

The Importance of Early Referral and Treatment for IPF

The France Foundation

What is the BEST treatment for pulmonary fibrosis ?

Interstitial Lung Disease Info

An Overview on Idiopathic Pulmonary Fibrosis

Demystifying Medicine McMaster

IPF Treatment: Starting on Pirfenidone

PlatformQ Health